Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bataille

Showing results (301-310 of 322) with videos related to

Pageof 33
Sort By:
British Journal of Cancer|June 11, 2008
Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomasD Loussouarn, L Campion, C Sagan, et al.
ACS Chemical Biology|September 15, 2018
Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based MDMX InhibitorsJakub Stefaniak, Andrew M Lewis, Daniel Conole, et al.
British Journal of Haematology|July 23, 1998
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patientsP Moreau, V Leblond, P Bourquelot, et al.
Blood|March 10, 2001
Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapyT Facon, H Avet-Loiseau, G Guillerm, et al.
Molecules (Basel, Switzerland)|November 13, 2021
Identification and Preliminary Structure-Activity Relationship Studies of 1,5-Dihydrobenzo[<i>e</i>][1,4]oxazepin-2(3<i>H</i>)-ones That Induce Differentiation of Acute Myeloid Leukemia Cells In VitroLaia Josa-Culleré, Thomas J Cogswell, Irene Georgiou, et al.
The European Journal of Neuroscience|November 9, 2023
Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson'sKatherine R Brimblecombe, Natalie Connor-Robson, Carole J R Bataille, et al.
Genes & Development|August 3, 2007
Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defenseJunichiro Sonoda, Josée Laganière, Isaac R Mehl, et al.
Blood|June 30, 2020
The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytesPeng Hua, Joanna Hester, George Adigbli, et al.
Plos Neglected Tropical Diseases|February 10, 2017
Dihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivoFrederick A Partridge, Emma A Murphy, Nicky J Willis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Validation of 213Bi-alpha radioimmunotherapy for multiple myelomaO Couturier, A Faivre-Chauvet, I V Filippovich, et al.
Pageof 33

Showing results (301-310 of 322) with videos related to

Sort By:
Pageof 33
British Journal of Cancer|June 11, 2008
Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomasD Loussouarn, L Campion, C Sagan, et al.
ACS Chemical Biology|September 15, 2018
Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based MDMX InhibitorsJakub Stefaniak, Andrew M Lewis, Daniel Conole, et al.
British Journal of Haematology|July 23, 1998
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patientsP Moreau, V Leblond, P Bourquelot, et al.
Blood|March 10, 2001
Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapyT Facon, H Avet-Loiseau, G Guillerm, et al.
Molecules (Basel, Switzerland)|November 13, 2021
Identification and Preliminary Structure-Activity Relationship Studies of 1,5-Dihydrobenzo[<i>e</i>][1,4]oxazepin-2(3<i>H</i>)-ones That Induce Differentiation of Acute Myeloid Leukemia Cells In VitroLaia Josa-Culleré, Thomas J Cogswell, Irene Georgiou, et al.
The European Journal of Neuroscience|November 9, 2023
Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson'sKatherine R Brimblecombe, Natalie Connor-Robson, Carole J R Bataille, et al.
Genes & Development|August 3, 2007
Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defenseJunichiro Sonoda, Josée Laganière, Isaac R Mehl, et al.
Blood|June 30, 2020
The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytesPeng Hua, Joanna Hester, George Adigbli, et al.
Plos Neglected Tropical Diseases|February 10, 2017
Dihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivoFrederick A Partridge, Emma A Murphy, Nicky J Willis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Validation of 213Bi-alpha radioimmunotherapy for multiple myelomaO Couturier, A Faivre-Chauvet, I V Filippovich, et al.
Pageof 33